drugset / Trial / NCT02471833
Health Evaluation in African Americans Using RAS Therapy
RandomizedParallel-groupDouble-blindPrevention
Summary
The purpose of this study is to determine if telmisartan, an FDA approved blood pressure medication, may also have beneficial effects on Alzheimer's disease prevention in African Americans, who are at high risk for Alzheimer's disease.
Timeline
- Start
- 2015-04
- Primary completion
- 2022-04-15
- Completion
- 2022-04-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Telmisartan | Other / unclassified | 20 mg | Oral |
| Subject | Telmisartan | Other / unclassified | 40 mg | Oral |